MPM BIOVENTURES 2018, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001729505. 10% Owner at Entrada Therapeutics, Inc. (TRDA) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in BOSTON, MA.
Companies MPM BIOVENTURES 2018, L.P. has filed insider reports for
- Entrada Therapeutics, Inc. (TRDA): 10% Owner
- Aktis Oncology, Inc. (AKTS): 10% Owner
- iTeos Therapeutics, Inc. (ITOS)
MPM BIOVENTURES 2018, L.P.
CIK: 0001729505
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 9, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect28.8K shares at avg. $7.13$206K - Sep 8, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect192.5K shares at avg. $7.41$1.4M - Sep 4, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect38.5K shares at avg. $7.11$274K - Sep 3, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect32.3K shares at avg. $7.17$231K - Sep 2, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect25.1K shares at avg. $7.19$181K - Sep 1, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect29.1K shares at avg. $7.06$205K - Aug 26, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect14.6K shares at avg. $7.06$103K - Aug 25, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect26.5K shares at avg. $7.54$200K - Aug 24, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect21.6K shares at avg. $7.34$159K - Jan 12, 2026AKTS
Aktis Oncology, Inc.
ConversionIndirect1.3M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  TRDA Entrada Therapeutics, Inc. | Sale | 28,837 | $7.13 | $205,608 | Indirect |
| Sep 8, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 192,500 | $7.41 | $1,426,425 | Indirect |
| Sep 4, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 38,500 | $7.11 | $273,735 | Indirect |
| Sep 3, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 32,263 | $7.17 | $231,326 | Indirect |
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 25,131 | $7.19 | $180,692 | Indirect |
| Sep 1, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 29,088 | $7.06 | $205,361 | Indirect |
| Aug 26, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 14,569 | $7.06 | $102,857 | Indirect |
| Aug 25, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 26,522 | $7.54 | $199,976 | Indirect |
| Aug 24, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 21,623 | $7.34 | $158,713 | Indirect |
| Jan 12, 2026 |  AKTS Aktis Oncology, Inc. | Conversion | 1,314,262 | - | $0 | Indirect |
1-10 of 16 transactions